[1]赵妍,郭佳欣,程健,等.肾脏免疫球蛋白沉积与糖尿病肾脏病的临床相关性研究[J].国际内分泌代谢杂志,2024,44(03):161-166.[doi:10.3760/cma.j.cn121383-20240124-01067]
　Zhao Yan,Guo Jiaxin,Cheng Jian,et al.Study on the clinical associations between different types of renal immunoglobulin deposition and diabetic kidney disease[J].International Journal of Endocrinology and Metabolism,2024,44(03):161-166.[doi:10.3760/cma.j.cn121383-20240124-01067]
点击复制

肾脏免疫球蛋白沉积与糖尿病肾脏病的临床相关性研究()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
44
期数:
2024年03期
页码:
161-166
栏目:
论著
出版日期:
2024-05-20

文章信息/Info

Title:
Study on the clinical associations between different types of renal immunoglobulin deposition and diabetic kidney disease
作者:
赵妍1; 郭佳欣2; 程健3; 祁伟4; 赵晶晶5
1天津医科大学第二医院内分泌科,天津 300211; 2天津市胸科医院内分泌科,天津 300222; 3中国科学院天津工业生物技术研究所,天津 300308; 4天津医科大学第二医院感染性疾病科,天津 300211; 5天津医科大学第二医院肾内科,天津 300211
Author(s):
Zhao Yan;  Guo Jiaxin;  Cheng Jian;  Qi Wei;  Zhao Jingjing.
1Department of Endocrinology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China; 2Department of Endocrinology, Tianjin Chest Hospital,Tianjin 300222, China; 3Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin 300308, China; 4Department of Infectious Diseases, The Second Hospital of Tianjin Medical University, Tianjin 300211, China; 5Department of Nephrology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China
关键词:
糖尿病肾脏病;  肾脏沉积;  免疫球蛋白;  肾脏终点事件
Keywords:
Diabetic kidney disease;  Renal deposition;  Immunoglobulin;  Renal endpoint event
DOI:
10.3760/cma.j.cn121383-20240124-01067
摘要:
目的 探讨肾脏免疫球蛋白沉积与糖尿病肾脏病(diabetic kidney disease,DKD)的临床相关性。方法 将肾活检确诊为DKD的患者分为4组:(1)一阳(IgA+IgM-IgG-/IgA-IgM+IgG-/IgA-IgM-IgG+)。(2)二阳(IgA+IgM+IgG-/IgA+IgM-IgG+/IgA-IgM+IgG+)。(3)全阳(IgA+IgM+IgG+)。(4)全阴(IgA-IgM-IgG-)。收集患者的临床资料,分析肾脏免疫球蛋白沉积与DKD的临床相关性,通过DKD的肾脏终点事件评估其对肾脏预后的预测价值。结果 全阳组患者的尿蛋白定量明显高于其他3组; 单因素COX回归分析示全阳组发生肾脏终点事件的风险更高,多因素COX回归分析示免疫球蛋白沉积对肾脏预后无统计学意义。结论 肾脏多种免疫球蛋白沉积增加了DKD尿蛋白的漏出,但与肾脏预后无明显相关性。
Abstract:
Objective To explore the clinical associations between different types of renal immunoglobulin deposition and diabetic kidney disease(DKD).Methods The patients diagnosed as DKD who underwent renal puncture biopsy were divided into four groups, which were as follows:(1)One-positive(IgA+ IgM- IgG-/IgA- IgM+ IgG-/IgA- IgM- IgG+);(2)Two-positive(IgA+ IgM+ IgG-/IgA+ IgM- IgG+/IgA- IgM+ IgG+);(3)All-positive(IgA+ IgM+ IgG+);(4)All-negative(IgA- IgM- IgG-).Clinical data of patients were collected to analyze the clinical correlation between renal immunoglobulin deposition and DKD, and the value of renal endpoint events was assessed to predict renal prognosis in DKD patients.Results The urinary protein quantity of the all-positive group was higher than that of the other three groups. Univariate COX regression analysis showed that the risk of renal endpoint events was higher in all-positive groups, while multi-factor COX regression analysis showed that immunoglobulin deposition had no statistical significance to renal outcome.Conclusion Multiple immunoglobulin deposition in the kidney increased urinary protein leakage in DKD patients, but there was no significant correlation with renal prognosis.

参考文献/References:

[1] Gupta S,Dominguez M,Golestaneh L.Diabetic kidney disease:an update[J].Med Clin North Am,2023,107(4):689-705.DOI: 10.1016/j.mcna.2023.03.004.
[2] Najafian B,Alpers CE,Fogo AB.Pathology of human diabetic nephropathy[J].Contrib Nephrol,2011,170:36-47.DOI:10.1159/000324942.
[3] Rizvi S,Raza ST,Mahdi F.Association of genetic variants with diabetic nephropathy[J].World J Diabetes,2014,5(6):809-816.DOI:10.4239/wjd.v5.i6.809.
[4] 刘晓雯.炎性指标与免疫学指标诊断糖尿病肾病及判断预后的临床价值[J].医学检验与临床,2019,30(2):55-57.DOI:10.3969/j.issn.1673-5013.2019.02.015.
[5] 李含雨.免疫球蛋白与糖尿病肾病研究进展[J].西部医学,2018,30(10):1554-1557.DOI:10.3969/j.issn.1672-3511.2018.10.037.
[6] Mise K,Hoshino J,Ueno T,et al.Clinical implications of linear immunofluorescent staining for immunoglobulin G in patients with diabetic nephropathy[J].Diabetes Res Clin Pract,2014,106(3):522-530.DOI:10.1016/j.diabres.2014.09.051.
[7] Tervaert TW,Mooyaart AL,Amann K,et al.Pathologic classification of diabetic nephropathy[J].J Am Soc Nephrol,2010,21(4):556-563.DOI:10.1681/ASN.2010010010.
[8] 郭晓艳,魏兰,王艳.原发性免疫球蛋白A肾病患者免疫球蛋白M沉积临床特征研究[J].临床军医杂志,2019,47(4):404-405.DOI:10.16680/j.1671-3826.2019.04.29.
[9] Tang X,Li H,Li L,et al.The clinical impact of glomerular immunoglobulin M deposition in patients with type 2 diabetic nephropathy[J].Am J Med Sci,2018,356(4):365-373.DOI:10.1016/j.amjms.2018.07.001.
[10] Ainsworth SK,Hirsch HZ,Brackett NC Jr,et al.Diabetic glomerulonephropathy:histopathologic,immunofluorescent,and ultrastructural studies of 16 cases[J].Hum Pathol,1982,13(50):470-478.DOI:10.1016/s0046-8177(82)80030-0.
[11] Forshaw MJ,Guirguis O,Hennigan TW.IgA nephropathy in association with Crohn’s disease[J].Int J Colorectal Dis,2005,20:463-465.DOI:10.1007/s00384-004-0696-z.
[12] Stefan G,Stancu S,Zugravu A,et al.Histologic predictors of renal outcome in diabetic nephropathy:beyond renal pathology society classification[J].Medicine(Baltimore),2019,98(27):e16333.DOI:10.1097/MD.0000000000016333.
[13] Bohle A,Wehrmann M,Bogenschütz O,et al.The pathogenesis of chronic renal failure in diabetic nephropathy.Investigation of 488 cases of diabetic glomerulosclerosis[J].Pathol Res Pract,1991,187(2-3):251-259.DOI:10.1016/s0344-0338(11)80780-6.

相似文献/References:

[1]中华医学会糖尿病学分会微血管并发症学组.中国糖尿病肾脏病防治指南(2021年版)[J].国际内分泌代谢杂志,2021,41(04):388.[doi:10.3760/cma.j.cn121383-20210825-08064]
　Microvascular Complications Group of Chinese Diabetes Society.Clinical guideline for the prevention and treatment of diabetic kidney disease in China(2021 edition)[J].International Journal of Endocrinology and Metabolism,2021,41(03):388.[doi:10.3760/cma.j.cn121383-20210825-08064]
[2]高忠爱,杨波,郑妙艳,等.糖尿病合并大量蛋白尿的中西医治疗策略[J].国际内分泌代谢杂志,2021,41(06):583.[doi:10.3760/cma.j.cn121383-20210930-09088]
　Gao Zhongai,Yang Bo,Zheng Miaoyan,et al.Treatment strategies of traditional Chinese and western medicine in diabetic patients with overt proteinuria[J].International Journal of Endocrinology and Metabolism,2021,41(03):583.[doi:10.3760/cma.j.cn121383-20210930-09088]
[3]谷巍,宋光耀,李晓龙.肾脏异位脂质沉积与糖尿病肾脏病脂毒性机制的研究进展[J].国际内分泌代谢杂志,2022,42(03):199.[doi:10.3760/cma.j.cn121383-20210324-03067]
　Gu Wei,Song Guangyao,Li Xiaolong..Research progress of renal ectopic lipid deposition and the mechanism of lipid toxicity in diabetic kidney disease[J].International Journal of Endocrinology and Metabolism,2022,42(03):199.[doi:10.3760/cma.j.cn121383-20210324-03067]
[4]黄婧荷,宋焱,郭立新.糖尿病肾脏病的磁共振成像评估方法及进展[J].国际内分泌代谢杂志,2023,43(04):309.[doi:10.3760/cma.j.cn121383-20220403-04007]
　Huang Jinghe,Song Yan,Guo Lixin.Magnetic resonance imaging in diabetic kidney disease:assessment and update[J].International Journal of Endocrinology and Metabolism,2023,43(03):309.[doi:10.3760/cma.j.cn121383-20220403-04007]
[5]范巧明,罗冬强,蔡惠连,等.基于生信分析及实验验证探讨中医药抗糖尿病肾脏病的组方规律及作用机制[J].国际内分泌代谢杂志,2024,44(03):155.[doi:10.3760/cma.j.cn121383-20231022-10037]
　Fan Qiaoming,Luo Dongqiang,Cai Huilian,et al.Based on bioinformatics analysis and experimental verification, the composition and mechanism of TCM anti-diabetic nephropathy were discussed[J].International Journal of Endocrinology and Metabolism,2024,44(03):155.[doi:10.3760/cma.j.cn121383-20231022-10037]

备注/Memo

备注/Memo:
通信作者:赵晶晶,Email: zhaojing_j@126.com
基金项目:国家自然科学基金(82202578); 天津市科技计划项目(23YDTPJC00990); 天津市卫生健康委员会中医中西医结合科研课题(2021077); 天津市教委科研计划项目(2023ZD003); 天津医科大学第二医院临床医学研究项目(2020LC14)
更新日期/Last Update: 2024-05-30